ZA765331B - Novel pharmaceutically active compounds - Google Patents
Novel pharmaceutically active compoundsInfo
- Publication number
- ZA765331B ZA765331B ZA765331A ZA765331A ZA765331B ZA 765331 B ZA765331 B ZA 765331B ZA 765331 A ZA765331 A ZA 765331A ZA 765331 A ZA765331 A ZA 765331A ZA 765331 B ZA765331 B ZA 765331B
- Authority
- ZA
- South Africa
- Prior art keywords
- active compounds
- pharmaceutically active
- novel pharmaceutically
- novel
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7510988A SE7510988L (en) | 1975-10-01 | 1975-10-01 | NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA765331B true ZA765331B (en) | 1977-08-31 |
Family
ID=20325688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA765331A ZA765331B (en) | 1975-10-01 | 1976-09-07 | Novel pharmaceutically active compounds |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5242840A (en) |
| AT (1) | AT347427B (en) |
| AU (1) | AU503212B2 (en) |
| BE (1) | BE846837A (en) |
| CS (2) | CS199644B2 (en) |
| DD (1) | DD126278A5 (en) |
| DE (1) | DE2640972A1 (en) |
| DK (1) | DK141622B (en) |
| ES (1) | ES451979A1 (en) |
| FI (1) | FI762660A (en) |
| FR (1) | FR2326183A1 (en) |
| GB (1) | GB1542317A (en) |
| LU (1) | LU75916A1 (en) |
| NL (1) | NL7610845A (en) |
| NO (1) | NO763345L (en) |
| NZ (1) | NZ182165A (en) |
| SE (1) | SE7510988L (en) |
| SU (2) | SU638252A3 (en) |
| ZA (1) | ZA765331B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1273A (en) | 1980-07-09 | 1985-03-08 | Draco Ab | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates |
| EP0103830A3 (en) * | 1982-09-22 | 1985-07-31 | Bayer Ag | Phenylethylemine derivatires as growth stimulators |
| EP2189448B1 (en) * | 2003-06-17 | 2014-01-29 | Arena Pharmaceuticals, Inc. | Processes for the Separation of 3-Benzazepine Racemates |
| EP2001852A2 (en) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| CA2670285A1 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| JP5491421B2 (en) | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Process for the preparation of intermediates related to the 5-HT2C agonist (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| CN102648170A (en) | 2009-06-18 | 2012-08-22 | 艾尼纳制药公司 | Processes for the preparation of 5-HT2C receptor agonists |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| CN103189360A (en) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | Non-hygroscopic salts of 5-HT2C agonists |
| EP2939677A1 (en) | 2010-09-01 | 2015-11-04 | Arena Pharmaceuticals, Inc. | Administration of lorcaserin to indviduals with renal impairment |
| ES2704455T3 (en) | 2010-09-01 | 2019-03-18 | Arena Pharm Inc | Pharmaceutical forms of modified release of 5-HT2C agonists useful for weight management |
| WO2012030938A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
| AU2012392187B2 (en) | 2012-10-09 | 2018-07-12 | Arena Pharmaceuticals, Inc. | Method of weight management |
-
1975
- 1975-10-01 SE SE7510988A patent/SE7510988L/en unknown
-
1976
- 1976-09-07 ZA ZA765331A patent/ZA765331B/en unknown
- 1976-09-11 DE DE19762640972 patent/DE2640972A1/en not_active Withdrawn
- 1976-09-15 AT AT682376A patent/AT347427B/en not_active IP Right Cessation
- 1976-09-16 FI FI762660A patent/FI762660A/fi not_active Application Discontinuation
- 1976-09-22 SU SU762402852A patent/SU638252A3/en active
- 1976-09-27 NZ NZ182165A patent/NZ182165A/en unknown
- 1976-09-27 AU AU18122/76A patent/AU503212B2/en not_active Expired
- 1976-09-28 DD DD195022A patent/DD126278A5/xx unknown
- 1976-09-30 NL NL7610845A patent/NL7610845A/en not_active Application Discontinuation
- 1976-09-30 LU LU75916A patent/LU75916A1/xx unknown
- 1976-09-30 NO NO763345A patent/NO763345L/no unknown
- 1976-09-30 GB GB7640684A patent/GB1542317A/en not_active Expired
- 1976-09-30 DK DK439776AA patent/DK141622B/en unknown
- 1976-09-30 ES ES451979A patent/ES451979A1/en not_active Expired
- 1976-09-30 FR FR7629467A patent/FR2326183A1/en not_active Withdrawn
- 1976-10-01 BE BE171148A patent/BE846837A/en unknown
- 1976-10-01 CS CS782253A patent/CS199644B2/en unknown
- 1976-10-01 JP JP51118924A patent/JPS5242840A/en active Pending
- 1976-10-01 CS CS766357A patent/CS199643B2/en unknown
-
1977
- 1977-10-13 SU SU772532454A patent/SU674669A3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| CS199643B2 (en) | 1980-07-31 |
| NL7610845A (en) | 1977-04-05 |
| SU674669A3 (en) | 1979-07-15 |
| GB1542317A (en) | 1979-03-14 |
| AT347427B (en) | 1978-12-27 |
| SU638252A3 (en) | 1978-12-15 |
| AU1812276A (en) | 1978-04-06 |
| DD126278A5 (en) | 1977-07-06 |
| DE2640972A1 (en) | 1977-04-14 |
| ATA682376A (en) | 1978-05-15 |
| LU75916A1 (en) | 1978-05-16 |
| BE846837A (en) | 1977-04-01 |
| AU503212B2 (en) | 1979-08-30 |
| JPS5242840A (en) | 1977-04-04 |
| FR2326183A1 (en) | 1977-04-29 |
| DK141622B (en) | 1980-05-12 |
| FI762660A (en) | 1977-04-02 |
| ES451979A1 (en) | 1978-01-01 |
| DK439776A (en) | 1977-04-02 |
| CS199644B2 (en) | 1980-07-31 |
| NZ182165A (en) | 1978-07-10 |
| SE7510988L (en) | 1977-04-02 |
| NO763345L (en) | 1977-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS51131843A (en) | Lipidddepleted active compound | |
| ZA776129B (en) | Pharmaceutically active compounds | |
| ZA763652B (en) | Pharmacologically active compounds | |
| ZA767198B (en) | Pharmacologically active compounds | |
| PT65590B (en) | Pharmacologically active compounds | |
| PT67046B (en) | Pharmacologically active compounds | |
| PT65348B (en) | Pharmacologically active compounds | |
| JPS5228945A (en) | Pharmaceutically active ooacyll 2*33diaryll33halogenn acrylaldoxim | |
| ZA765331B (en) | Novel pharmaceutically active compounds | |
| ZA7682B (en) | Pharmacologically active compounds | |
| ZM9676A1 (en) | Pharmacologically active compounds | |
| PT66255A (en) | Pharmacologically active compounds | |
| ZA761324B (en) | Pharmaceutically active compounds | |
| ZA763837B (en) | Pharmacologically active compounds | |
| PT65839A (en) | Pharmacologically active compounds | |
| ZA762536B (en) | Pharmacologically active compounds | |
| ZA774220B (en) | Pharmacologically active compounds | |
| GB1487036A (en) | Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives | |
| GB1483448A (en) | Therapeutically active basic ethers | |
| ZA766201B (en) | Pharmacologically active compounds | |
| JPS5283745A (en) | Pharmaceutically active compound | |
| ZA76390B (en) | Pharmacologically active compositions | |
| ZA764183B (en) | Pharmaceutically active peptides | |
| MW2776A1 (en) | Pharmacologically active compounds | |
| MW2676A1 (en) | Pharmacologically active compounds |